Biotech Growth Investors & VC Firms
747 firms in this list, with a median first check of $1M. 169 of them lead rounds. Generated from verified public data and updated continuously.
Dimension Capital
San FranciscoSeed–Late Stage$1M – $10M
13 people
Quan Capital
ShanghaiSeed–Late Stage
16 people
UCL Technology Fund
LondonPre-Seed–Growth$320K – $9M
13 people
Magnum Industrial Partners Tres S.L.
MadridGrowth–Late Stage
15 people
Indico Capital Partners
LisbonSeed–Growth$250K – $10M
15 people
Better Ventures Central Llc
OaklandPre-Seed–Growth$500K – $1.5M
4 people
Odyssey Investment Partners
New YorkGrowth–Late Stage$100M – $300M
14 people
Tenmile
Seed–Growth
11 people
Lauxera Capital Partners
ParisGrowth–Late Stage$22M – $110M
16 people
MaRS
TorontoPre-Seed–Late Stage
19 people
AN Venture Partners
TokyoPre-Seed–Growth
21 people
LVX Ventures
BangalorePre-Seed–Late Stage
Thorney Investment Group
MelbourneSeed–Late Stage
23 people
CITIC Capital Holdings
Hong KongGrowth–Late Stage
21 people
Delos Capital
CambridgeSeed–Late Stage
12 people
Prime Partners
TokyoPre-Seed–Growth
Asahi Kasei Corporate Venture Capital
Menlo ParkPre-Seed–Late Stage$500K – $3M
19 people
Shoreline Venture Management
San Francisco Bay AreaSeed–Growth$250K – $8M
13 people
Vensana Capital
MinneapolisSeries A–Late Stage
13 people
Hundreds Capital
BeijingSeed–Late Stage
3 people
SQN Venture Partners, LLC
CharlestonSeed–Late Stage
7 people
V-Bio Ventures
GhentSeed–Growth$270K – $2.2M
13 people
NovaCapital
Seed–Late Stage
9 people
Keensight Capital
ParisGrowth–Late Stage$10M – $800M
2 people
Related lists
Growth Investors & VC Firms (4757)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)Biotech Series A Investors & VC Firms (1596)Growth Investors & VC Firms in United States (1502)Growth Investors & VC Firms in Global (1414)Healthtech Growth Investors & VC Firms (1213)Enterprise Software Growth Investors & VC Firms (1186)SaaS Growth Investors & VC Firms (1173)Growth Investors & VC Firms in Europe (1149)
Data sourced from public filings and firms' own websites — see our methodology.





























































